Characterization of remission levels in patients with ulcerative colitis treated with 5-aminosalicylates: results of the cross-sectional CARUC-ASA study by the Belgian IBD Research and Development Group

Inflammatory Bowel Disease

Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study

Lancet Gastroenterol Hepatol

Visser E, Reijntjes MA, Heuthorst L, Stellingwerf ME, West R, van Dongen K, Crolla RMPH, van Dieren S, van der Bilt JDW, Bemelman WA, D'Haens GR, Buskens CJ, COSTA Study Group

doi: 10.1016/S2468-1253(25)00291-2

RECOMMENDED

Inflammatory Bowel Disease

Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study

★ 3 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Inflamm Bowel Dis

Kucharzik T, Helwig U, Seibold F, Biedermann L, Högenauer C, Fischer I, Hammer L, Rath S, Maaser C

doi: 10.1093/ibd/izag074

RECOMMENDED

Inflammatory Bowel Disease

Efficacy of 5-Aminosalicylic Acid Continuation versus Discontinuation in Patients with Ulcerative Colitis Escalated to Advanced Therapy: A Systematic Review and Meta-Analysis of Adjusted Effect Estimates

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

J Crohns Colitis

Sul HH, Gewehr DM, Kang H, Junior OR, Ungaro RC, Bernstein CN

doi: 10.1093/ecco-jcc/jjaf202

Inflammatory Bowel Disease

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid

Inflamm Bowel Dis

Yarur A, Irving P, Siegmund B, Dubinsky MC, Ananthakrishnan AN, Regueiro M, Ungaro RC, Ritter T, Nakase H, Liu Z, Mehra D, Osterman MT, Jain A, Rubin DT, Hibi T

doi: 10.1093/ibd/izaf195

Inflammatory Bowel Disease

Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN

J Crohns Colitis

Trivić Mažuranić I, Aloi M, Bramuzzo M, Chiantese C, D'Arcangelo G, Gattenlöhner S, Gianolio L, Granot M, Hızarcıoğlu Gülşen H, Hussey S, Kang B, Kolho KL, de Laffolie J, Lega S, Martinelli M, Matar M, Mayer C, Miele E, Norsa L, Panarese I, Rinawi F, Rohani P, Romano C, Sansotta N, Scarallo L, Shouval DS, Staiano A, Strisciuglio C, Tomas D, Yerushalmy-Feler A, Zojaji R, Hojsak I

doi: 10.1093/ecco-jcc/jjag074

Inflammatory Bowel Disease

Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN

Gastroenterology

Scarallo L, Alvisi P, Bramuzzo M, Domanico A, Kierkus J, Matar M, Strisciuglio C, De Laffolie J, Broekaert I, Aloi M, Rodríguez-Belvís MV, Renzo S, Labriola F, Tasciotti L, Dragoni G, Lionetti P

doi: 10.1053/j.gastro.2026.02.034

Inflammatory Bowel Disease

Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Lancet Gastroenterol Hepatol

Wu K, Zheng C, Cao Q, Ding Y, Gao X, Zhong J, Chiu CT, Zhang H, Wang X, Wang B, Liang J, Liu X, Zhou Y, Xu B, Kim TO, Shen X, Chen D, Chen W, Liu Y, Shen J, Liu F, Ding X, Zhan Q, Chou JW, Zeng S, Lin Y, Ying L, Chen X, ENLIGHT UC Study Group

doi: 10.1016/S2468-1253(25)00198-0

Inflammatory Bowel Disease

Trends in Use of Prescribed Opioids in Incident and Prevalent Patients With Ulcerative Colitis: A Nationwide Study in Sweden

Inflamm Bowel Dis

Osooli M, Voghera S, Bruze G, Nordenvall C, Hedin CRH, Everhov ÅH, Myrelid P, Ludvigsson JF, Olén O, SWIBREG Study Group§

doi: 10.1093/ibd/izaf278

Inflammatory Bowel Disease

Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry

Inflamm Bowel Dis

Guasch M, Calafat M, Gargallo-Puyuelo CJ, De Francisco R, Moraleja I, Vega P, de Castro L, Labarga F, Mesonero F, Castro-Poceiro J, Ponferrada-Díaz A, Brunet-Mas E, Sesé E, Ramos L, Quiñones M, Ruiz-Cerulla A, Castro B, Zabana Y, Iglesias E, Latras I, Varela P, Ricart E, Madero L, Elosua A, Vicente L, Lorente R, Betoré E, Roig C, Mañosa M, Domènech E, PERICO-ENEIDA Study of the GETECCU

doi: 10.1093/ibd/izag120

Related content

Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study

Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study

Efficacy of 5-Aminosalicylic Acid Continuation versus Discontinuation in Patients with Ulcerative Colitis Escalated to Advanced Therapy: A Systematic Review and Meta-Analysis of Adjusted Effect Estimates

Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid

Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN

Intestinal Ultrasound Scan in Acute Severe Ulcerative Colitis in children: a multicenter prospective study on behalf of the Porto IBD Working Group of ESPGHAN

Etrasimod as induction and maintenance treatment for patients with moderately to severely active ulcerative colitis in East Asia (ENLIGHT UC): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Trends in Use of Prescribed Opioids in Incident and Prevalent Patients With Ulcerative Colitis: A Nationwide Study in Sweden

Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry